A detailed history of Fox Run Management, L.L.C. transactions in Astrazeneca PLC stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 22,614 shares of AZN stock, worth $1.71 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
22,614
Holding current value
$1.71 Million
% of portfolio
0.28%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$63.2 - $79.58 $1.43 Million - $1.8 Million
22,614 New
22,614 $1.48 Million
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $76,631 - $92,712
-1,147 Reduced 8.44%
12,445 $970,000
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $829,519 - $945,595
13,592 New
13,592 $920,000
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $708,188 - $767,955
10,130 New
10,130 $725,000
Q4 2022

Feb 07, 2023

BUY
$54.21 - $70.44 $398,660 - $518,015
7,354 New
7,354 $498,000
Q1 2022

May 10, 2022

SELL
$55.72 - $67.12 $271,690 - $327,277
-4,876 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$54.02 - $63.83 $263,401 - $311,235
4,876 New
4,876 $284,000
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $241,257 - $286,713
-5,682 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$40.12 - $45.47 $227,961 - $258,360
5,682 New
5,682 $253,000
Q2 2019

Jul 17, 2019

SELL
$37.28 - $41.68 $695,122 - $777,165
-18,646 Closed
0 $0
Q1 2019

Oct 17, 2019

SELL
$35.49 - $43.02 $9,049 - $10,970
-255 Reduced 1.35%
18,646 $754,000
Q4 2018

Jan 15, 2019

BUY
$36.86 - $41.49 $696,690 - $784,202
18,901 New
18,901 $718,000
Q3 2018

Oct 05, 2018

SELL
$34.76 - $39.72 $302,412 - $345,564
-8,700 Closed
0 $0
Q2 2018

Jul 17, 2018

SELL
$34.55 - $37.05 $537,667 - $576,572
-15,562 Reduced 64.14%
8,700 $305,000
Q1 2018

Apr 17, 2018

BUY
$32.97 - $36.63 $799,918 - $888,717
24,262 New
24,262 $848,000
Q4 2017

Jan 18, 2018

SELL
$32.09 - $34.78 $901,729 - $977,318
-28,100 Closed
0 $0
Q3 2017

Oct 23, 2017

BUY
$28.96 - $34.0 $813,776 - $955,400
28,100
28,100 $952,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $234B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.